Sue Siegel Hugh Alderwick Sabine Vuik Chris Ham Hannah Patel
This paper argues that while providing healthcare is important there needs to be a shift beyond traditional forms of health treatment through medical prescription by giving way to the induction of support groups in societies that can have more of an impact.
The Healthy Populations Forum will seek to define the concept of population health, explain why a strategy is needed to address it, and list actions for policymakers to improve it. By discussing case studies based on community and employer-led initiatives, healthcare systems and city-wide approaches, the paper will lay out a framework for a population health management strategy that will translate into actionable policy recommendations. Among the topics the report will cover are the significance of technology and innovation in enhancing the health of populations, in both low and high-income countries. It will shed light on how technology has transformed the way healthcare is delivered in certain countries, while identifying possible interventions that lead to short and long-term impact.
Sue Siegel is CEO of GE Ventures, GE’s growth and innovation business comprised of GE Ventures, GE Licensing, and New Business Creation (NBC). GE Ventures invests in and partners with the entrepreneurial ecosystem across Healthcare, Energy, Software, Advanced Manufacturing, and Lighting and starts and grows companies via its New Business Creation unit. GE Licensing creates shareholder value through GE’s IP. She also leads Healthymagination, GE’s innovation catalyst for addressing healthcare’s major global challenges via partnerships to improve the quality, access, and affordability of healthcare. Sue has 30+ years of combined experiences in the corporate world and in venture capital. Previously, as a Silicon Valley-based financial VC, Sue led investments in personalized medicine, digital health, and life sciences at MDV. Before venture capital, she drove strategy and technology development as well as new market creation & development at Bio-Rad, DuPont, Amersham, and Affymetrix (NASDAQ: AFFX). As President and Board Member of Affymetrix, Sue led the company’s transformation from a pre-revenue start up to a global, multi-billion dollar market cap genomics leader. Sue has served on dozens of private and public corporate boards, along with non-profit boards. She currently serves on the Boards of: the National Venture Capital Association, Stanford Hospital Board’s IT Council, University of California’s Innovation Council, Harvard Partners’ Innovation Advisory Board, the Cleveland Clinic’s Innovation Council, USC’s Schaeffer Center for Health Policy, and serves on the Executive Committee of Santa Clara University’s Miller Center for Social Entrepreneurship. Most recently she served on President Obama’s Precision Medicine Initiative as a member of the Working Group to set guidelines for its establishment. She is a President’s Circle member of the National Academies of Science, a member of YPO-WPO, Women Corporate Directors, and a Henry Crown Fellow of the Aspen Institute. Sue serves on the President’s Precision Medicine Council and served as a Board member for the NIH’s National Center for Advancing Translation Sciences. In the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter, Sue was a featured “Multiplier”. She was recognized as one of “The 100 Most Influential Women in Silicon Valley”. Sue lives in Silicon Valley with her husband and her two sons. When not working, you might find her hiking the scenic trails of Northern California.